Equities

Virpax Pharmaceuticals Inc

VRPX:NAQ

Virpax Pharmaceuticals Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)0.756
  • Today's Change0.001 / 0.13%
  • Shares traded42.23k
  • 1 Year change-90.18%
  • Beta1.1358
Data delayed at least 15 minutes, as of Sep 18 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Key statistics

On Wednesday, Virpax Pharmaceuticals Inc (VRPX:NAQ) closed at 0.756, 64.24% above the 52 week low of 0.4603 set on Jun 21, 2024.
52-week range
Today
0.4603Jun 21 20249.00Oct 09 2023
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Open0.764
High0.8022
Low0.755
Bid0.7553
Offer0.7697
Previous close0.755
Average volume63.97k
Shares outstanding4.89m
Free float4.59m
P/E (TTM)--
Market cap3.69m USD
EPS (TTM)-13.51
USD
Data delayed at least 15 minutes, as of Sep 18 2024 21:00 BST.
More ▼

Events & Activity

  • VRPX:NAQ price moved over +6.25% to 0.8022
  • VRPX:NAQ price rises above 15-day moving average to 0.8022 at 10:31 BST
  • VRPX:NAQ price rises above 15-day moving average to 0.8199 at 12:41 BST
  • VRPX:NAQ price falls below 15-day moving average to 0.804 at 11:00 BST
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.